Surgical Management of the Diabetic Foot in End-Stage Kidney Disease: An Integrated Anatomical Nephrological and Vascular-Surgical Perspective
Ioana Livia Suliman, Florin Gabriel Panculescu, Marius Florentin Popa, Constantin Dina, Lucian Serbanescu, Alexandru Vicentiu Valcu, Florin Daniel Enache, Teodor Stefan Nitu, Stere Popescu, Dragoş Fasie, Bogdan Campineanu, Liliana-Ana Ţuţa, Bogdan ObadaReview Articles, no. 3, 2026
Article DOI: 10.21614/chirurgia.3307
Diabetic foot disease in end-stage kidney disease (ESKD) represents the convergence of diabetic peripheral neuropathy, accelerated atherosclerosis, medial arterial calcification, uremic immune dysfunction and impaired wound healing. The combination yields amputation rates three- to five-fold higher than in non-uremic diabetics and one-year postamputation mortality approaching 40â?"50%. In this paper we synthesised the current anatomical, diabetological, nephrological and surgical evidence into a practical framework for the surgeon caring for the dialysis-dependent or kidney-transplant recipient with a diabetic foot. We conducted a narrative review of guidelines and consensus statements from the American Diabetes Association (ADA) Standards of Care 2025, KDIGO 2022/2024, the 2023 intersocietal International Working Group on the Diabetic Foot (IWGDF), European Society for Vascular Surgery (ESVS) and Society for Vascular Surgery (SVS) PAD guideline, the 2024 ACC/AHA Lower-Extremity PAD Guideline, the 2019 Global Vascular Guidelines on chronic limb-threatening ischemia (CLTI), and the KDOQI 2019/2020 vascular access update, supplemented by high-quality reviews published through 2026. Anatomical understanding of the tibioperoneal trifurcation, pedal-plantar loop and the angiosomal territories is now central to revascularization planning; belowthe- knee disease in ESKD is diffuse, calcified and pedal-dominant, mandating individualized choice between bypass, endovascular and transcatheter arterialization of the deep veins; perioperative care must integrate dialysis timing, hyperkalaemia control, anaemia and mineral-bone disease management, and ipsilateral vascular-access preservation; the threshold to definitive, well-planned amputation should be lower than in non-uremic diabetics, but only after a structured limb-salvage attempt within a multidisciplinary "toe-and-flow" team.
Keywords: diabetic foot, end-stage kidney disease, chronic limb-threatening ischemia, revascularization, medial arterial calcification, angiosome, transcatheter arterialization of deep veins, KDIGO, IWGDF, amputation



